The stock of BioAffinity Technologies Inc (BIAF) has gone down by -8.48% for the week, with a 21.60% rise in the past month and a 67.10% rise in the past quarter. The volatility ratio for the week is 11.92%, and the volatility levels for the past 30 days are 12.15% for BIAF. The simple moving average for the past 20 days is 4.39% for BIAF’s stock, with a 53.09% simple moving average for the past 200 days.
Is It Worth Investing in BioAffinity Technologies Inc (NASDAQ: BIAF) Right Now?
Company’s 36-month beta value is 2.60.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for BIAF is 5.54M, and currently, short sellers hold a 1.00% ratio of that floaft. The average trading volume of BIAF on April 24, 2024 was 220.03K shares.
BIAF) stock’s latest price update
The stock price of BioAffinity Technologies Inc (NASDAQ: BIAF) has dropped by -13.67 compared to previous close of 3.00. Despite this, the company has seen a fall of -8.48% in its stock price over the last five trading days. Business Wire reported 2022-11-08 that SAN ANTONIO–(BUSINESS WIRE)– #BIAF–bioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW) today announced that the Company will host a conference call and audio webcast on Monday, Nov. 14, 2022, at 8 a.m.
BIAF Trading at 22.96% from the 50-Day Moving Average
After a stumble in the market that brought BIAF to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -28.45% of loss for the given period.
Volatility was left at 12.15%, however, over the last 30 days, the volatility rate increased by 11.92%, as shares surge +22.17% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +63.92% upper at present.
During the last 5 trading sessions, BIAF fell by -8.48%, which changed the moving average for the period of 200-days by +43.09% in comparison to the 20-day moving average, which settled at $2.50. In addition, BioAffinity Technologies Inc saw 76.13% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for BIAF
Current profitability levels for the company are sitting at:
- -3.15 for the present operating margin
- 0.25 for the gross margin
The net margin for BioAffinity Technologies Inc stands at -3.13. The total capital return value is set at -1.33. Equity return is now at value -99.84, with -77.80 for asset returns.
Based on BioAffinity Technologies Inc (BIAF), the company’s capital structure generated 0.25 points at debt to capital in total, while cash flow to debt ratio is standing at -3.82. The debt to equity ratio resting at 0.33. The interest coverage ratio of the stock is -0.22.
Currently, EBITDA for the company is -7.72 million with net debt to EBITDA at 0.16. When we switch over and look at the enterprise to sales, we see a ratio of 11.28. The receivables turnover for the company is 3.12for trailing twelve months and the total asset turnover is 0.31. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.77.
Conclusion
In a nutshell, BioAffinity Technologies Inc (BIAF) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
